Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Other Accumulated Expenses (2016 - 2026)

Ekso Bionics Holdings has reported Other Accumulated Expenses over the past 6 years, most recently at $218000.0 for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 12.37% to $218000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $218000.0, a 12.37% increase, with the full-year FY2025 number at $218000.0, up 12.37% from a year prior.
  • Other Accumulated Expenses reached $218000.0 in Q4 2025 per EKSO's latest filing, down from $244000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $256000.0 in Q2 2023, with the low at $97000.0 in Q2 2024.
  • The 4-year median for Other Accumulated Expenses is $157000.0 (2022), against an average of $168666.7.
  • Peak YoY movement for Other Accumulated Expenses: crashed 62.11% in 2024, then surged 106.78% in 2025.
  • Tracing EKSO's Other Accumulated Expenses over 4 years: stood at $161000.0 in 2022, then dropped by 9.94% to $145000.0 in 2023, then soared by 33.79% to $194000.0 in 2024, then increased by 12.37% to $218000.0 in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $218000.0, $244000.0, and $153000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.